Related Experiment Video
Updated: Sep 10, 2025
10:10
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
Published on: November 2, 2018
9.4K
Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third
Debra A Thompson1, K Thiran Jayasundera1, Oleg Alekseev2
1Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.
Translational Vision Science & Technology
|August 27, 2025
Summary
Genetic therapies for inherited retinal diseases show promise but face regulatory hurdles. Recommendations focus on collaboration, patient support, and streamlined approvals for precision medicine development.
Area of Science:
- Ophthalmology
- Genetics
- Pharmacology
Background:
- Genetic therapies for inherited retinal diseases (IRDs) have progressed significantly over the last decade.
- Clinical trials and treatment development demonstrate optimism for precision medicine in rare IRDs.
Purpose of the Study:
- To summarize recent advances and challenges in developing therapeutics for IRDs.
- To provide recommendations for advancing the field of IRD therapeutics.
Main Methods:
- Review of recent progress in genetic therapy development for IRDs.
- Analysis of challenges impacting regulatory approvals.
- Identification of priority areas for future development.
Main Results:
- Despite advances, regulatory approval challenges persist for IRD therapies.
- Key areas for progress include patient support, understanding disease mechanisms, outcome measures, and therapy approvals.
Conclusions:
- Restructuring collaborative efforts into comprehensive, well-resourced enterprises is crucial.
- Integrated approaches across science, business, and medicine are needed to overcome challenges and advance IRD therapeutics.
